Angel Yeast Showcases Sustainable Protein Innovation at Growth Asia Summit 2026
Angel Yeast (SSE: 600298) presented its latest yeast protein innovations at the Growth Asia Summit 2026 held in Singapore from 8‑10 July 2026. On the second day, dedicated to Active Lifestyles, Weight Management, Protein and Healthier Product Innovation, Chen Zhixian, General Manager of the Nutrition and Health Technology Center, delivered a presentation covering the company’s yeast protein portfolio, recent R&D progress and application development.
Citing Chinese Center for Disease Control and Prevention data, Chen noted that total protein intake in China has been stable over four decades but the composition has shifted: animal protein now represents 39.5 % of intake, up from 11 %, while legume‑based protein fell from 13 % to 6.1 %. Approximately 45 % of the population does not consume enough dietary protein, a shortfall most acute among older adults and rural communities.
Angel Yeast highlighted AngeoPro, the first microbial protein ingredient approved in China, which delivers a protein content of over 80 % and is available in soluble, gel‑type and dispersible forms. AngeoPro carries a PDCAAS score of 1.0, making it a complete, high‑quality protein. It is already commercialised in five segments: sports nutrition, senior supplements, bakery and snacks, dairy alternatives, and plant‑based foods. Ongoing research is exploring benefits for immunity, muscle health, post‑exercise recovery, bone strength and digestive wellness.
The summit also underscored a regional pivot toward food‑based, snackable, on‑the‑go protein formats, with functional nutrition moving from supplement aisles into everyday meals such as high‑protein cheeses, protein bars, ready‑to‑drink shakes and functional cereals. Widespread nutrient gaps in protein, iron and vitamin D across India and Southeast Asia are driving demand for affordable, high‑quality protein solutions.
In line with these trends, Angel Yeast launched a new range of functional yeast proteins in 2026, each tailored to specific applications and emerging market opportunities. The company announced that its new manufacturing facility in Indonesia is on track to commence operations in 2027, a move expected to significantly reduce lead times, tariffs and logistics costs across the Southeast Asian market.
\"Angel's long‑term goal is to pioneer the global protein revolution, letting everyone enjoy sustainable and healthier protein every day,\" said Chen. \"We'll continue to expand the global adoption of yeast protein through innovative biomanufacturing to address protein supply challenges and lead a protein transformation that benefits people everywhere.\"